The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
2017-2018 application process for submission of LoI is now closed
Candidates selected to submit a Full Proposal will be contacted on May 16th